Antioxidants,
Journal Year:
2025,
Volume and Issue:
14(3), P. 331 - 331
Published: March 11, 2025
Charcot-Marie-Tooth
disease
(CMT)
is
the
most
common
hereditary
peripheral
neuropathy
worldwide,
presenting
clinically
as
muscle
weakness
that
progresses
to
impaired
ambulation
or
quadriplegia
with
age.
CMT1A,
subtype,
caused
by
a
duplication
in
PMP22,
encoding
an
essential
membrane
protein
for
Schwann
cell
myelin
integrity.
While
mechanisms
of
neurodegeneration
CMT1A
are
poorly
understood,
excessive
oxidative
stress,
particularly
lipid
peroxidation,
known
pathological
feature,
and
antioxidant
therapy
has
reversed
phenotype
mouse
model.
For
first
time,
we
define
pathogenic
link
between
ferroptosis,
form
regulated
death
peroxidation
hindered
defenses.
Human-derived
fibroblasts
showed
greater
susceptibility
RSL3,
pro-ferroptosis
agent,
compared
controls,
alongside
several
ferroptosis
markers,
including
elevated
peroxides
depleted
GPX4,
critical
anti-ferroptosis
repressor.
Similarly,
transcriptomic
analysis
human
iPSC-derived
cells
revealed
activation
cellular
stress
markers
CMT1A.
We
propose
chronic,
sublethal
ferroptotic
mediated
peroxide
accumulation,
depletes
defenses
cells,
leading
decompensation
age,
manifesting
symptomatic
disease.
These
results
emphasize
driver
pathology,
potentially
revealing
new
therapeutic
path.
Immunity,
Journal Year:
2024,
Volume and Issue:
57(5), P. 941 - 956
Published: May 1, 2024
Ferroptosis
is
a
type
of
regulated
cell
death
that
drives
the
pathophysiology
many
diseases.
Oxidative
stress
detectable
in
types
death,
but
only
ferroptosis
involves
lipid
peroxidation
and
iron
dependency.
originates
propagates
from
several
organelles,
including
mitochondria,
endoplasmic
reticulum,
Golgi,
lysosomes.
Recent
data
have
revealed
immune
cells
can
both
induce
undergo
ferroptosis.
A
mechanistic
understanding
how
regulates
immunity
critical
to
controls
responses
this
dysregulated
disease.
Translationally,
more
work
needed
produce
ferroptosis-modulating
immunotherapeutics.
This
review
focuses
on
role
immune-related
diseases,
infection,
autoimmune
cancer.
We
discuss
immunity,
regulation
contributes
disease
pathogenesis,
targeting
may
lead
novel
therapies.
Materials Horizons,
Journal Year:
2024,
Volume and Issue:
11(13), P. 3082 - 3089
Published: Jan. 1, 2024
Polycatechols
modulate
amyloid-associated
toxicities,
arrest
labile
iron,
inhibit
lipid
peroxidation,
and
regulate
tau
liquid–liquid
phase
separation
(LLPS)
to
mitigate
the
pathological
nexus
between
ferroptosis
AD.
MedComm,
Journal Year:
2024,
Volume and Issue:
5(12)
Published: Nov. 20, 2024
Ferroptosis
is
a
nonapoptotic
form
of
cell
death
characterized
by
iron-dependent
lipid
peroxidation
in
membrane
phospholipids.
Since
its
identification
2012,
extensive
research
has
unveiled
involvement
the
pathophysiology
numerous
diseases,
including
cancers,
neurodegenerative
disorders,
organ
injuries,
infectious
autoimmune
conditions,
metabolic
and
skin
diseases.
Oxidizable
lipids,
overload
iron,
compromised
antioxidant
systems
are
known
as
critical
prerequisites
for
driving
overwhelming
peroxidation,
ultimately
leading
to
plasma
rupture
ferroptotic
death.
However,
precise
regulatory
networks
governing
ferroptosis
ferroptosis-targeted
therapy
these
diseases
remain
largely
undefined,
hindering
development
pharmacological
agonists
antagonists.
In
this
review,
we
first
elucidate
core
mechanisms
summarize
epigenetic
modifications
(e.g.,
histone
modifications,
DNA
methylation,
noncoding
RNAs,
N6-methyladenosine
modification)
nonepigenetic
genetic
mutations,
transcriptional
regulation,
posttranslational
modifications).
We
then
discuss
association
between
disease
pathogenesis
explore
therapeutic
approaches
targeting
ferroptosis.
also
introduce
potential
clinical
monitoring
strategies
Finally,
put
forward
several
unresolved
issues
which
progress
needed
better
understand
hope
review
will
offer
promise
application
therapies
context
human
health
disease.
BMC Biology,
Journal Year:
2025,
Volume and Issue:
23(1)
Published: Feb. 4, 2025
Lung
ischemia–reperfusion
(I/R)
injury
is
a
common
clinical
pathology
associated
with
high
mortality.
The
pathophysiology
of
lung
I/R
involves
ferroptosis
and
elevated
protein
O-GlcNAcylation
levels,
while
the
effect
on
remains
unclear.
This
research
aimed
to
explore
reducing
in
pulmonary
epithelial
cells
caused
by
I/R.
First,
we
identified
O-GlcNAc
transferase
1
(Ogt1)
as
differentially
expressed
gene
acute
injury/acute
respiratory
distress
syndrome
(ALI/ARDS)
patients,
using
single-cell
sequencing,
Gene
Ontology
analysis
(GO
analysis)
revealed
enrichment
process.
We
found
time-dependent
dynamic
alteration
during
injury.
Proteomics
proteins
enriched
multiple
redox-related
pathways
based
KEGG
annotation.
Thus,
generated
Ogt1-conditional
knockout
mice
that
Ogt1
deficiency
aggravated
ferroptosis,
evidenced
lipid
reactive
oxygen
species
(lipid
ROS),
malondialdehyde
(MDA),
Fe2+,
well
alterations
critical
expression
glutathione
peroxidase
4
(GPX4)
solute
carrier
family
7
member
11
(SLC7A11).
Consistently,
inhibited
sensitivity
hypoxia/reoxygenation
(H/R)
injury-induced
TC-1
via
O-GlcNAcylated
NF-E2-related
factor-2
(Nrf2).
Furthermore,
both
chromatin
immunoprecipitation
(ChIP)
assay
dual-luciferase
reporter
indicated
Nrf2
could
bind
translation
start
site
(TSS)
glucose-6-phosphate
dehydrogenase
(G6PDH)
promote
its
transcriptional
activity.
As
an
important
rate-limiting
enzyme
pentose
phosphate
pathway
(PPP),
G6PDH
provided
mass
nicotinamide
adenine
dinucleotide
(NADPH)
improve
redox
state
(GSH)
eventually
led
resistance.
Rescue
experiments
proved
knockdown
or
Nrf2-T334A
(O-GlcNAcylation
site)
mutation
abolished
protective
In
summary,
protect
against
Nrf2/G6PDH
pathway.
Our
work
will
provide
new
basis
for
therapeutic
strategies
ischemia–reperfusion-induced
Cell Death and Disease,
Journal Year:
2023,
Volume and Issue:
14(11)
Published: Nov. 25, 2023
Abstract
Ferroptosis
is
an
iron-
and
reactive
oxygen
species
(ROS)-dependent
form
of
regulated
cell
death,
that
has
been
implicated
in
Alzheimer’s
disease
Parkinson’s
disease.
Inhibition
cystine/glutamate
antiporter
could
lead
to
mitochondrial
fragmentation,
calcium
([Ca
2+
]
m
)
overload,
increased
ROS
production,
disruption
the
membrane
potential
(ΔΨ
),
ferroptotic
death.
The
observation
dysfunction
a
characteristic
ferroptosis
makes
preservation
function
therapeutic
option
for
diseases
associated
with
Mitochondrial
levels
are
controlled
via
uniporter
(MCU),
main
entry
point
Ca
into
matrix.
Therefore,
we
have
hypothesized
negative
modulation
MCU
complex
may
confer
protection
against
ferroptosis.
Here
evaluated
whether
known
modulators
complex,
ruthenium
red
(RR),
its
derivative
Ru265,
mitoxantrone
(MX),
MCU-i4
can
prevent
These
compounds
mediated
HT22
cells,
human
dopaminergic
neurons
mouse
primary
cortical
Depletion
MICU1,
[Ca
gatekeeper,
demonstrated
MICU
protective
Taken
together,
our
results
reveal
represents
degenerative
conditions,
which
central
progression
these
pathologies.